Correlation Between Expression of MDR1/P-gp Gene and CerbB-2,p53 Genes and its Clinical Significance in Breast Cancer
Ailin Zhang
Abstract
Ailin Zhang
Abstract
Objective To investigate the correlation between expression of MDR1/P-gp gene and CerbB-2,p53 genes and its clinical significance in breast cancer.Methods SP immunohistochemical method was used to detect the expression of MDR1/P-gp gene and CerbB-2,p53 genes in breast cancer.Results The positive rates of expression of MDR1/P-gp,CerbB-2,and p53 were 41.4%,51.1% and 38.7 %,respectively.The overexpression rate of CerbB-2 was significantly higher in the group with expression of P-gp(37.66%)than that in the group with non-expression of P-gp(20.18%).The overexpression rate of p53 was also higher in the group with expression of P-gp(28.57%)than that in the group with non-expression of P-gp(15.60%).The expression of P-gp was not correlated with tumor diameter,lymph node metastasis,clinical stages,pathological types and the receptors for estrogen and progestogen(P0.05).The positive rate of CerbB-2 and p53 expression was significantly increased in axillary lymph node positive breast cancer.Conclusions MDR1/P-gp,CerbB-2 and p53 are co-expressed in breast cancer and have a relationship with multidrug resistance.Combined detection might be useful in the establishment of synthetic therapy regimen in breast cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the correlation between expression of MDR1/P-gp gene and CerbB-2,p53 genes and its clinical significance in breast cancer.Methods SP immunohistochemical method was used to detect the expression of MDR1/P-gp gene and CerbB-2,p53 genes in breast cancer.Results The positive rates of expression of MDR1/P-gp,CerbB-2,and p53 were 41.4%,51.1% and 38.7 %,respectively.The overexpression rate of CerbB-2 was significantly higher in the group with expression of P-gp(37.66%)than that in the group with non-expression of P-gp(20.18%).The overexpression rate of p53 was also higher in the group with expression of P-gp(28.57%)than that in the group with non-expression of P-gp(15.60%).The expression of P-gp was not correlated with tumor diameter,lymph node metastasis,clinical stages,pathological types and the receptors for estrogen and progestogen(P0.05).The positive rate of CerbB-2 and p53 expression was significantly increased in axillary lymph node positive breast cancer.Conclusions MDR1/P-gp,CerbB-2 and p53 are co-expressed in breast cancer and have a relationship with multidrug resistance.Combined detection might be useful in the establishment of synthetic therapy regimen in breast cancer.
Key concepts: Breast cancer, Oncology, Internal medicine, Cancer research, Gene, Immunohistochemistry, Progestogen, Medicine